Basics Aligos Therapeutics, Inc. IPO Date: October 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $55.69M Activated in VL: True Average Daily Range Avg Daily Range: $0.44 | 4.41% Avg Daily Range (30 D): $0.55 | 5.34% Avg Daily Range (90 D): $0.43 | 4.59% Institutional Daily Volume Avg Daily Volume: .19M Avg Daily Volume (30 D): .06M Avg Daily Volume (90 D): .07M Trade Size Avg Trade Size (Sh.): 134 Avg Trade Size (Sh.) (30 D): 84 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 103 Avg Inst. Trade: $2.37M Avg Inst. Trade (30 D): $1.07M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.3M Avg Closing Trade (30 D): $.69M Avg Closing Trade (90 D): $.69M Avg Closing Volume: 13.54K     News Dec 12, 2025 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Jordyn Tarazi Nov 14, 2025 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Jordyn Tarazi May 16, 2025 @ 12:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: N/A Mar 14, 2025 @ 12:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Aligos Therapeutics, Inc. Mar 3, 2025 @ 1:00 PM Aligos Therapeutics to Announce 4th Quarter 2024 F... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-13.54 $-3.04 $-1.53 Diluted EPS $-13.54 $-3.04 $-1.53 Revenue $ 2.62M $ .74M $ .97M Gross Profit $ $ $ Net Income / Loss $ -86.46M $ -31.54M $ -15.86M Operating Income / Loss $ -86.73M $ -28.36M $ -18.57M Cost of Revenue $ $ $ Net Cash Flow $ 6.62M $ 23.29M $ -55.1M PE Ratio     Splits Aug 19, 2024:   1:25